Effects of orally administrated mosapride, a 5-HT4 receptor agonist on the digestive tract of horses

Journal of Equine Science

Volumn 15, Issue 3, 2004, Pages 81-84

  Sasaki, Naoki ^a   Lee, Inhyung ^a   Ayukawa, Yu ^a   Yamada, Haruo ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

5 HT4 receptor agonist; Equine; Gastrokinetic agent; Mosapride; Oral adoministration

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

EID: 12344277964     PISSN: 13403516     EISSN: None     Source Type: Journal    
DOI: 10.1294/jes.15.81     Document Type: Article

References (28)

1. Ahmad, S. R. and Wolfe, S. M. 1995. Cisapride and torsades de pointes. Lancet 345: 508.
2. Bran, Q.T., Murray, W.A., Hirsch, I.B., and Palmar, J.P. 1995. Long QT syndrome duration high-dose cisapride. Arch. Intern. Med. 155: 765-768.
3. Carlsson, L., Amos, G., Andresson, B., Drews, L. Duker, G., and Wadstedt, G. 1997. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic protential? J. Pharmacol. Exp. 282: 220-227.
4. Chen, J. and Mccallum, R.W. 1993. Clinical applications of electrogastrography. Am. J. Gastro. 88: 1324-1336.
5. Cucchiara, S., Salvia, G., Borrelli, O., Ciccimara, E., Az-Zeqeh, N., Rapagiolo, S., Minella, R., Campanozzi, A., and Riezzo, G. 1997. Gastric electrical dysrhythmias and delayed gastric emptying in gastroesophageal reflux disease. Am. J. Gastroenterol. 92: 1103-1108.
6. Kajimoto, T. 1995. Relation between electrogastrography and gastric electromyogram mechanical activity. J. Smooth Muscle Res. 31: 93-107.
7. Kanaizumi, T. Nakano, H., Matsui, T., Ishikawa, H., Shimizu, R., and Paku, S. 1990. Effect of AS-4370 on gastric emptying - Double-blind clinical pharmacological study -. Jpn. J. Smooth. Muscle. Res. 26: 161-174.
8. Kanaizumi, T., Nakano, H., Matsui, Y., Ishikawa, H., Park, S., and Kuriya, N. 1991. Prokinetic effect of AS-4370 on gastric emptying in healthy adults. Eur. J. Clin. Pharmacol. 41: 335-337.
9. Kato, S., Morie, T., Kon, T., Yoshida, N., Karasawa, T., and Matsumoto, J. 1991. Novel benzamides as selective and potent gastrokinetic agents. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N- benzamide citrate (AS-4370) and related compounds. J. Med. Chem. 34: 616-624.
10. Kato, S., Morie, T., and Yoshida, N. 1995. Synthesis and biological activities of metabolites of mosapride, a new gastroprokinetic agent. Chem. Pharm. Bull. 43: 699-702.
11. Kato, S., Morie, T., and Yoshida, N. 1996. Synthesis and biological activity of 4-amino-5-chloro-2-ethoxy-3-hydroxybenzamides, metabolites of a new gastroprokinetic agent, mosapride. Chem. Pharm. Bull. 44: 1484-1492.
12. Kato, S., Fujiwara, I., and Yoshida, N. 1999. Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents. Med. Res. Rev. 1: 25-73.
13. 4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac potentials in guinea pig isolated papillary muscles. J. Cardiovasc. Pharmacol. 29: 670-675.
14. 4 receptor agonists on gastrointestinal motility in two and in vitro. J. Pharmacol. Exp. 283: 1000-1008.
15. Morie, T., Kato, S., Harada, H., Yoshida, N., and Matsumoto, J. 1994. Synthesis and biological activities of optical isomers of 4-amino-5-chloro-2- ethoxy-N-benzamide Mosapride. Chem. Pharm. Bull. 42: 877-882.
16. Pillans, P. 1995. Bronchospasm associated with cisapride. Lancet 311: 1472.
17. Ruth, M., Hamelin, B., Rohss, K. and Lundell, L. 1998. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastrooesophageal reflux disease. Aliment pharmacol. Ther. 12: 35-40.
18. Sasaki, N., Mizuno, Y., and Yoshihara, T. 1999. The application of electrocecography for evaluation of cecum motility in horses. J. Vet. Med. Sci. 60: 1221-1226.
19. Sasaki, N. and Hara, S. 2003. Medical treatment to equine gastrointestinal dysfunctions. J. Vet. Equine Sci. 14: 37-49.
20. Sasaki, N and Yoshihara, T. 2000. The Effect of Orally Administered Cisapride on Intestinal Motility in Conscious Horses. J. Vet. Med. Sci. 62: 211-213.
21. Taniyama, K., Kakimoto, N., Furuichi, A., Yamashita, Y., Nagase, Y., Kaibara, M., and Kanematsu, T. 2000. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J. Gastroenterol. 35: 575-582.
22. Thor, P., Lorens, K., Tabor, S., Herman, R., Konturek, J.W., and Konturek, S.J. 1996. Dysfunction in gastric myoelectric and motor activity in hericobacter pylori positive gastritis patients with non-ulcer dyspepsia. J. Physiol. Pharmcol. 47: 469-476.
23. 4 receptor in the intestinal tract and striatum of the guinea pig. Life Sci. 59: 2129-2137.
24. Weiss, R., Abel, D., Scholtysik, G. Straub, R., and Mevissen, M. 2002. 5-Hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT4 agonist. J. Vet. Pharmacol Ther. 25: 49-58.
25. Yamashita, Y., Takada, K. Takemura, K., Yamashita, K., Enjoji, A., Kanematsu, T., and Taniyama, K. 1999. Ability of mosapride to bind to 5-HT4 receptor in the human stomach. J. Med. Chem. 79: 493-496.
26. Yoshida, N., Ito, T. Karasawa, T., and Itoh, Z. 1991. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J. Pharmacol. Exp. 257: 781-787.
27. Yoshida, N., Omoya, H., Kato, S., and Ito, T. 1993. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Arzneim. Forsch. Drug. Res. 43: 1078-1083.
28. Yoshida, N. 1999. Pharmacological effects of the gastroprokinetic agent mosapride citrate. Folia Pharmacol. Jpn. 113: 299-307.